Tapentadol is partially metabolized by the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with prescription drugs that enrich or repress the action/expression of one or more of those enzymes, as well as with substrates of these enzymes (as a consequence of Competitiveness for that enzyme); some enzyme mediators/substrat… Read More